Autocrine TGFβ signaling mediates vitamin D3 analog-induced growth inhibition in breast cells

Journal of Cellular Physiology

Volumn 188, Issue 3, 2001, Pages 383-393

  Yang, Limin ^a   Yang, Junhua ^a   Venkateswarlu, Srinivas ^a   Ko, Tien ^b   Brattain, Michael G ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 20 EPICALCITRIOL; COLECALCIFEROL DERIVATIVE; COMPLEMENTARY DNA; NEUTRALIZING ANTIBODY; RNA; SEOCALCITOL; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; VITAMIN D RECEPTOR; ACTIVIN RECEPTOR 1; ANTINEOPLASTIC AGENT; BLOCKING ANTIBODY; CALCITRIOL; CALCITRIOL RECEPTOR; COLECALCIFEROL; DNA BINDING PROTEIN; DRUG DERIVATIVE; PROTEIN SERINE THREONINE KINASE; SMAD3 PROTEIN; SMAD3 PROTEIN, HUMAN; TGF BETA TYPE I RECEPTOR; TGF-BETA TYPE I RECEPTOR; THYMIDINE; TRANSACTIVATOR PROTEIN; TRANSFORMING GROWTH FACTOR BETA TYPE II RECEPTOR; TRANSFORMING GROWTH FACTOR-BETA TYPE II RECEPTOR;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CONTROLLED STUDY; ENZYME ACTIVITY; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; AUTOCRINE EFFECT; BIOSYNTHESIS; BREAST; BREAST TUMOR; CELL DIVISION; CELL LINE; CYTOLOGY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; GENE EXPRESSION; GENETIC TRANSFECTION; GENETICS; METABOLISM; REPORTER GENE;

ACTIVIN RECEPTORS, TYPE I; ANTIBODIES, BLOCKING; ANTINEOPLASTIC AGENTS; AUTOCRINE COMMUNICATION; BREAST; BREAST NEOPLASMS; CALCITRIOL; CELL DIVISION; CELL LINE; CHOLECALCIFEROL; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION; GENES, REPORTER; HUMANS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, CALCITRIOL; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; SMAD3 PROTEIN; THYMIDINE; TRANS-ACTIVATORS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 0034742410     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.1125     Document Type: Article

References (54)

1. Defferentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3
2. An assay for transforming growth factor beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct
3. Growth stimulation of human breast cancer cells with anti-transforming factor beta antibodies: Evidence for negative autocrine regulation of transforming growth factor beta
4. A calcitrol analogue, EB1089, inhibits the growth of LNCaP tumors in nude mice
5. Defects of TGFβ receptor signaling in mammary cell tumorigenesis
6. MEKK-1, a component of the stress (stress-activated protein kinase/c-Jun N-terminal kinase) pathway, can selectively activate Smad2-mediated transcriptional activation in endothelial cells
7. Suppression of transforming growth factor-beta-induced apoptosis through a phosphatidylinositol 3-kinase/Akt-dependent pathway
8. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
9. Effects of synthetic vitamin D analogues on breast cancer cell proliferation in vivo and in vitro
10. Sensitive induction of apoptosis in breast cancer cells by a novel 1,25 dihydroxyvitamin D3 analogue shows relation to promoter selectivity
11. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: Possible implications for prevention and therapy
12. Epidermal growth factor impairs the cytochrome C/caspase-3 apoptotic pathway induced by transforming growth factor beta in rat fetal hepatocytes via a phosphoinositide 3-kinase-dependent pathway
13. The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for smad3 in TGF-beta-induced transcriptional activation
14. TGFβ latency: Biological significance and mechanisms of activation
15. A phase I study of the vitamin D analogue EB1089 in patients with advanced breast and colorectal cancer
16. TGFβ acts as an autocrine negative growth regulator in colon enterocytic differentiation but not in goblet cell maturation
17. Seocalcitol (EB 1089): A vitamin D analogue of anti-cancer potential. Background, design, synthesis, pre-clinical and clinical evaluation
18. 1 Alpha,25-dihydroxyvitamin D3 inhibits normal human keratinocyte growth by increasing transforming growth factor beta 2 release
19. 1 Alpha,25-dihydroxyvitamin D(3)-induced myeloid cell differentiation is regulated by a vitamin D receptor-phosphatidylinositol 3-kinase signaling complex
20. Molecular mechanisms of transforming growth factor-β signaling
21. Molecular mechanism of vitamin D receptor action
22. Effects of 1,25 dihydroxy-vitamin D3 and its analogues on induction of apoptosis in breast cancer cells
23. EB1089, a synthetic analogue of vitamin D, induces apoptosis in breast cancer cells in vivo and in vitro
24. TGFβ-stimulated cooperation of smad proteins with the coactivators CBP/p300
25. Decreased stability of transforming growth factor beta type II receptor mRNA in RER+ human colon carcinoma cells
26. Vitamin D analogues up-regulate p21 and p27 during growth inhibition of pancreatic cancer cell lines
27. 1,25-Dihydroxy-vitamin-D3 enhances antiproliferative effect and transcript TGFβ-beta 1 on human keratinocytes in culture
28. 1,25-Dihydroxyvitamin D3 increases nuclear vitamin D3 receptors by blocking ubiquitin/proteasome-mediated degradation in human skin
29. Evidence that phosphatidylinositol 3-kinase and p70S6K protein are involved in differentiation of HL-60 cells induced by calcitriol
30. Tamoxifen in the treatment of breast cancer
31. Intracellular signaling: Fleshing out the TGF-beta pathway
32. Mammary tumor suppression by transforming growth factor beta 1 transgene expression
33. The role of vitamin D endocrine system in health and disease
34. Correlation of insulin-like growth factor-binding protein-3 messenger RNA with protein expression in primary breast cancer tissues: Detection of higher levels in tumors with poor prognostic features
35. Hepatitis B virus X protein inhibits transforming growth factor-beta-induced apoptesis through the activation of phosphatidylinositol 3-kinase pathway
36. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10
37. The transforming growth factor-betas: Past, present, and future
38. Human mammary epithelial cells in culture: Differentiation and transformation
39. Expression of TGFβ type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells
40. 1 Alpha, 25-dehydroxyvitamin D3 synergism toward transforming growth factor beta-induced AP-1 transcriptional activity in mouse osteoblastic cells via receptor
41. Action of 1,25(OH) 2D3 on the cell cycle genes, cyclin D1, p21 and p27 in MCF-7 cells
42. Demonstration that mutation of the type II TGFβ receptor inactivates its tumor suppressor activity in RER positive colon carcinoma cells
43. Reduced expression of TGFβ type I receptor contributes to the malignancy of human colon carcinoma cells
44. TGFβ1 is an autocrine negative growth regulator of human colon carcinoma FET cells in vitro as revealed by transfection of an anti-sense expression vector
45. Repression of autocrine TGFβ1 and β2 in quiescent CBS colon carcinoma cells leads to progression of tumorigenic properties
46. Modulation of cell cycle control by vitamin D3 and its analogue, EB1089, in human breast cancer cells
47. 1 Alpha,25-Dihydroxyvitamin D3 increases transforming growth factor and transforming growth factor receptor type I and II synthesis in human bone
48. Regulation of TGFβ type II receptor expression in human breast cancer MCF-7 cells by vitamin D3 and its analogues
49. Identification of α,25dihydroxyvitamin D3 response elements in the human transforming growth factor β2 gene
50. Convergence of transforming growth factor-β and vitamin D signaling pathways on SMAD transcriptional coactivators
51. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor
52. Growth factor-depoendent survival of rodent fibroblasts requires phosphatidylinositol 3-kinase but is independent of pp70S6K activity
53. Contextual effects of TGFβ on the tumorigenicity of human colon carcinoma cells
54. Regulation of Smad signaling by protein associations and signaling crosstalk